Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome (Q61241): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/605176031 / rank | |||
Normal rank | |||
Revision as of 08:43, 14 August 2026
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_605176031 |
||
| English | Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome |
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects. |
